OnabotulinumtoxinA for the prevention of chronic migraine in adolescents: the experience of an italian third level headache center

被引：0
|
作者：
Frattale, I. [1 ]
Ursitti, F. [1 ]
Sforza, G. [1 ]
Monte, G. [1 ]
Ferilli, M. A. N. [1 ]
Tarantino, S. [1 ]
Checchi, M. Proietti [1 ]
Valeriani, M. [1 ]
Papetti, L. [1 ]
机构：
[1] Bambino Gesu Pediat Hosp, Dev Neurol Unit, Rome, Italy
来源：
JOURNAL OF HEADACHE AND PAIN | 2024年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P157
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Multidisciplinary approach to patients with chronic migraine and medication overuse: experience at the Besta Headache Center
    Grazzi, L.
    NEUROLOGICAL SCIENCES, 2013, 34 (01) : S19 - S21
  • [32] OnabotulinumtoxinA (Botox) for Chronic Migraine during pregnancy; experience from Hull (UK) Headache clinic over 11 years
    Khan, Rafiullah
    Khalil, Modar
    Buture, Alina
    Wong, Ho-Tin
    Ahmed, Fayyaz
    CEPHALALGIA, 2023, 43 (1supp) : 231 - 231
  • [33] Ketogenic diet in migraine: an experience of pediatric headache center
    Sforza, G.
    Moavero, R.
    Papetti, L.
    Ursitti, F.
    Monte, G.
    Tarantino, S.
    Checchi, M. Proietti
    Valeriani, M.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [34] Botulinum Toxin A in Chronic Migraine Headache in Children and Adolescents
    Kabbouche, M.
    O'Brien, H.
    LeCates, S.
    Cherney, S.
    Vaughan, P.
    Manning, P.
    Segers, A.
    Bush, J.
    Hershey, A.
    HEADACHE, 2011, 51 : 47 - 47
  • [35] A Quality of Life questionnaire for adolescents with chronic headache or migraine
    Dahlof, CGH
    CEPHALALGIA, 1996, 16 (03) : 137 - 137
  • [36] Botox Treatment for Migraine and Chronic Daily Headache in Adolescents
    Chan, Valerie W.
    McCabe, E. Jane
    MacGregor, Daune L.
    JOURNAL OF NEUROSCIENCE NURSING, 2009, 41 (05) : 235 - 243
  • [37] Assessment of the relative effectiveness of erenumab compared with onabotulinumtoxinA for the prevention of chronic migraine
    Mahon, Ronan
    Vo, Pamela
    Pannagl, Katharina
    Tiwari, Santosh
    Heemstra, Harald
    Ferraris, Matias
    Zhao, Jing
    Betts, Keith A.
    Proot, Pascal
    CURRENT MEDICAL RESEARCH AND OPINION, 2023, 39 (01) : 105 - 112
  • [38] Chronic primary headaches in children and adolescents referred to two third level headache centres
    Capuano, A.
    Bartoli, B.
    Frusciante, R.
    Vigevano, F.
    Termine, C.
    Valeriani, M.
    CEPHALALGIA, 2015, 35 : 196 - 197
  • [39] Real-world effectiveness of add-on fremanezumab in patients receiving onabotulinumtoxinA for chronic migraine in a US tertiary headache center
    Cohen, Fred
    Yuan, Hsiangkuo
    Dent, Kathryn
    Beucherie, Matthew
    Connolly, William
    Driessen, Maurice
    Krasenbaum, Lynda J.
    Carr, Karen
    Hopkins, Mary
    Marmura, Michael
    CEPHALALGIA, 2022, 42 (1_SUPPL) : 127 - 128
  • [40] Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation
    Bendtsen, Lars
    Sacco, Simona
    Ashina, Messoud
    Mitsikostas, Dimos
    Ahmed, Fayyaz
    Pozo-Rosich, Patricia
    Martelletti, Paolo
    JOURNAL OF HEADACHE AND PAIN, 2018, 19 : 91
12345